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Susann Lehmann, Joseph J Bass and Nathaniel J Szewczyk*Abstract
Background: Kinases are important signalling molecules for modulating cellular processes and major targets of
drug discovery programs. However, functional information for roughly half the human kinome is lacking. We
conducted three kinome wide, >90%, RNAi screens and epistasis testing of some identified kinases against known
intramuscular signalling systems to increase the functional annotation of the C. elegans kinome and expand our
understanding of kinome influence upon muscle protein degradation.
Results: 96 kinases were identified as required for normal protein homeostasis, 74 for normal mitochondrial
networks and 50 for normal sarcomere structure. Knockdown of kinases required only for normal protein
homeostasis and/or mitochondrial structure was significantly less likely to produce a developmental or behavioural
phenotype than knockdown of kinases required for normal sarcomere structure and/or other sub-cellular processes.
Lastly, assessment of kinases for which knockdown produced muscle protein degradation against the known
regulatory pathways in C. elegans muscle revealed that close to half of kinase knockdowns activated autophagy in a
MAPK dependent fashion.
Conclusions: Roughly 40% of kinases studied, 159 of 397, are important in establishing or maintaining muscle cell
health, with most required for both. For kinases where decreased expression triggers protein degradation,
autophagy is most commonly activated. These results increase the annotation of the C. elegans kinome to roughly
75% and enable future kinome research. As 33% of kinases identified have orthologues expressed in human muscle,
our results also enable testing of whether identified kinases function similarly in maintaining human muscle
homeostasis.
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Kinases are enzymes that alter proteins and lipids by
phosphorylation, the addition of a phosphate group. This
modification can influence a protein’s steric structure
and cause changes in protein-protein binding affinities
and enzyme activities [1]. Kinase encoding genes consti-
tute 2% of the human genome making kinases one of* Correspondence: nate@alumni.cmu.edu
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reproduction in any medium, provided the orthe largest protein families, which is termed the kinome.
Kinases also appear to play a major role in modulating
cellular processes as roughly 30% of intracellular proteins
are phosphate bound at any given time [2]. Accordingly,
kinase inhibitors account for a large part of drug discovery
programs in the pharmaceutical industry. Roughly 150
inhibitors of 42 well validated kinase targets are cur-
rently being tested in clinical trials [3]. These 42 targets
constitute only about 8% of the kinome. Although fur-
ther progress is being made in identifying the function
of already well-known kinases in the regulation ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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largely uncharacterized [3]. Thus, we lack an under-
standing of the complexity of process modulation by a
considerable part of the kinome. In this study, we took a
multi-level functional genomics approach to identify
kinases required for normal function of individual and
multiple processes within a single tissue in vivo.
To accomplish this work we employed the soil nematode
Caenorhabditis elegans as it is a convenient multicellular
organism for systems biology research [4]. The C. elegans
kinome contains 438 kinases which have been assigned to
168 subfamilies [5]. Of these subfamilies, 153 are shared
with the human kinome [5]. This conservation suggests
that 81% of human kinases have homologues in C. elegans.
Despite knowledge of these kinase encoding genes, several
functional genomic screens looking at the developmental
and behavioural effects of RNA interference against
each gene in the genome [6,7], and the effort to knock
out every gene in the genome [4], the C. elegans kinome
still appears understudied. A search of the C. elegans
database, www.wormbase.org [8], reveals that only roughly
60% of all kinase-encoding genes have been assigned a
genetic or RNAi phenotype.
As several past studies failed to detect a developmental
or behavioural effect of RNAi against kinase encoding
genes, we studied the effect of kinase knockdown by
RNAi on subcellular processes within muscle. We chose
muscle as it is a highly regulated, adaptable tissue that
responds to environmental inputs such as use and nutri-
tion in a balanced fashion in order to maintain whole body
homeostasis. Additionally, identification of new therapeutic
targets for modulating muscle homeostasis is desirable as
inability to maintain muscle can become a major health
concern. Severe wasting of muscle is associated with condi-
tions such as disuse, starvation, several diseases, and inevit-
ably occurs in the elderly [9].
To study the kinome requirement for establishing and
maintaining cellular homeostasis, we picked two pro-
cesses that occur in all cell types, protein homeostasis
and mitochondrial dynamics, and one process that is
specific to muscle, sarcomere assembly and maintenance.
We obtained previously utilized RNAi constructs and ex-
amined the effect of knockdown of each kinase upon each
process in muscle. We established that 159 kinase-
encoding genes, 40% of the C. elegans kinome screened
[5], appear to influence sub-cellular processes within
muscle. Of these 159 genes, 64% appear to be required to
maintain homeostasis of fully differentiated adult muscle,
32% appear to be required for multiple sub-cellular pro-
cesses, and 50% have identified human orthologues [5,10]
of which 53 are reported to be expressed in human skel-
etal muscle [11] (Additional file 1). This quantifies the
kinome requirement for normal development and main-
tenance of a single tissue in vivo and assigns RNAiphenotypes to 51 kinases for which no phenotype was pre-
viously assigned by genetic or RNAi approaches. Similar
to a past study of genes known to influence muscle func-
tion [12], we found that individual kinases were most fre-
quently required for proper protein homeostasis and least
frequently required for proper sarcomere structure. This
suggests that past studies aimed at understanding genomic
control of sarcomere structure [13,14] have only begun to
uncover the complexity of genomic control of muscle.
To better understand the nature of the kinome re-
quirement for maintenance of muscle homeostasis, we
performed epistasis tests with kinases whose knockdown
triggered muscle protein degradation against known pro-
teolytic signalling mechanisms in C. elegans muscle.
While knockdown of individual kinases triggered differ-
ent types of protein degradation, mitogen activated pro-
tein kinase MPK-1 dependent autophagy was triggered
in close to half of the knockdowns that triggered degrad-
ation. Our results not only contribute to the global un-
derstanding of the kinome, they may also lead to the
discovery of new therapeutic targets for the modulation
of muscle homeostasis.
Results
Kinases required for normal protein synthesis and
degradation in muscle
Modulation of global protein synthesis, degradation, or
both, can lead to either cellular hypertrophy or atrophy. In
multicellular organisms these processes must be regulated
such that adjacent cells can grow or shrink together. For
example, adult C. elegans muscle and hypodermis undergo
coordinated hypertrophy [15]. Similarly, regulation is re-
quired so that one tissue does not receive inordinate nutri-
ents. For example, tumours circumvent such regulation. In
man, several extramuscular signals are known to affect
protein homeostasis in muscle and are thought to do so via
a number of mechanisms, rather than via a single mech-
anism [16]; however in many cases the transducing sig-
nals or mechanisms are not known or are inadequately
understood.
To study the effects of altered kinase signalling on
cytosolic protein homeostasis, termed proteostasis, we
used a well-established C. elegans model [17,18]. In
this model a myosin heavy chain gene promoter and
enhancer drive the expression of a lacZ reporter trans-
gene to report on alterations in muscle protein synthesis.
As β-galactosidase synthesis stops when animals reach
adulthood and the β-galactosidase remains stable for at
least 72 hours [17], loss of β-galactosidase in response
to acute interventions indicates that degradation, not a
reduction in protein synthesis, is occurring in fully
differentiated adult muscles. Chronic RNAi knockdown
of 96 genes resulted in altered levels of β-galactosidase
activity, suggesting that these genes are required for
Figure 1 (See legend on next page.)
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Figure 1 Kinases that appear to be required for normal muscle protein synthesis and/or degradation. (A) Sample images of normal
β-galactosidase reporter staining (dark blue) in control, non-RNAi treated, PD55 animal (left) and RNAi treated animals showing decreased
β-galactosidase reporter staining. RNAi treatments are indicated in the lower right corner. Scale bars represent 100 μm. (B) Kinases identified as
required for normal lack of protein degradation in muscle. Indicated RNAi treatments were conducted chronically and followed up acutely and
scored for decreased β-galactosidase reporter staining, see materials and methods. Displayed are scoring data for each time point (n = 20-30).
Green indicates staining not appreciably different from controls. Red indicates that at least 25% of scored animals displayed lighter/diffuse blue or
lack of blue staining versus controls. Dark red indicates that at least 50% of scored animals displayed light/diffuse blue or lack of blue staining
versus controls. (C) Kinases identified as required for normal protein homeostasis in muscle. RNAi treatments were conducted and scored as in
(B) however the listed treatments produced a defect in the chronic screen but not the acute screen. – Indicates lack of data for a given time
point. ‡ Indicates a treatment was classed as producing a lack of progeny in this screen.
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ation (Figure 1). At least some of these 96 kinases are
likely to be required for normal protein synthesis during
development, for example EGL-15 which is required for
proper muscle development [19], but further experi-
ments are required to confirm to what extent genes
identified in the chronic screen may regulate synthesis,
degradation, or both. To determine if decreased levels
of β-galactosidase activity could be accounted for by in-
creased protein degradation alone, we knocked down
the identified genes acutely. We also acutely knocked
down genes for which a lack of progeny prohibited full
analysis in the chronic screen. Using this approach we
identified 48 kinases that appear to be required to pre-
vent abnormal muscle protein degradation (Figure 1).
Two of the 48 kinases, pat-4 and unc-82, have recently
been shown to be negative regulators of muscle protein
degradation in C. elegans [15] and two, gsk-3 [20] and
sgk-1 [21], are known to interact with insulin signalling
which is also a known regulator of muscle protein deg-
radation in C. elegans [22]. Thus, some of the results
from the screen appear to validate our approach. As
expected, several kinases without known phenotypes in
mutants or in response to RNAi were found to be re-
quired for normal protein synthesis and/or degradation
or required to prevent abnormal protein degradation
(Additional file 1). Lastly, the identification of ire-1 and
pek-1, which are well conserved regulators of the endo-
plasmic reticulum unfolded protein response [23] demon-
strates that, as expected, some of the identified kinases act
to maintain protein homeostasis not just in muscle, but in
most tissues.Kinases required for normal mitochondrial network
structure
It is now widely accepted that mitochondrial networks are
dynamic, undergoing morphological changes to maintain
organelle homeostasis or to respond to the metabolic
changes within the cell [24]. Advances have been made in
determining the mechanisms of mitochondrial organellar
quality control; it is however still unclear how mitochon-
dria integrate multiple cellular signals into fission andfusion processes and to what extent mitochondria are
self-regulated.
In order to gain insight into the kinome requirement
for normal mitochondrial structure in muscle, we exam-
ined mitochondrial morphology in C. elegans containing
mitochondrial localized GFP [25] (Figure 2). Chronic
RNAi knockdown of 74 kinase encoding genes induced
a fragmented mitochondrial network suggesting that
these kinases are required for proper establishment and/
or maintenance of the mitochondrial network in muscle.
Included within these 74 genes is pink-1, which encodes
PTEN-induced putative kinase 1, and which when mu-
tated in Drosophila melanogaster is known to induce
mitochondrial morphology defects in muscle as well as
other tissues [26]. Utilizing a pink-1 knockout allele, see
materials and methods, we confirmed that loss of func-
tion of pink-1 results in fragmentation of the mitochon-
drial network in muscle. To determine if disrupted
mitochondrial morphology could be attributed to a kin-
ase requirement for maintenance of the mitochondrial
network in muscle we knocked down the identified
kinase encoding genes acutely in adults. We also acutely
knocked down genes for which a lack of progeny
prohibited full analysis in the chronic screen. Using this
approach we identified 44 kinases that appear to be
required for proper maintenance of the mitochondrial
network in muscle (Figure 2). Within this set of 44 genes
is kin-1, which is already known to be involved in the
maintenance of mitochondrial networks [27]. As was the
case with the screen for kinases required for protein
homeostasis, the identification of known regulators of
mitochondrial dynamics appears to support our ap-
proach and, as expected, several kinases without known
phenotypes in mutants or in response to RNAi were
found to be required for normal mitochondrial network
structure (Additional file 1).
Kinases required for normal sarcomere assembly and
maintenance
In addition to studying two processes that occur in
most tissues, we studied the kinome requirement for a
muscle specific process. For this we chose sarcomere
assembly and maintenance, as the most recognized
Figure 2 (See legend on next page.)
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Figure 2 Kinases that appear to be required for normal mitochondrial network structure. (A) Sample images of GFP labelled
mitochondrial networks, and nuclei (large over exposed circles), showing normal mitochondrial network structure in control, non-RNAi treated,
CB5600 animal (left) and RNAi treated animals showing disrupted network structure. RNAi treatments are indicated in the lower right corner.
Scale bars represent 20 μm. (B) Kinases identified as required for normal maintenance of mitochondrial network structure in adult muscle.
Indicated RNAi treatments were conducted chronically and followed up acutely and scored for loss of mitochondrial network organization, see
materials and methods. Displayed are scoring data for each time point (n = 20-30). Green indicates networks not appreciably different from
controls. Red indicates that at least 25% of scored animals displayed disrupted mitochondrial network structure versus controls. Dark red indicates
that at least 50% of scored animals displayed disrupted mitochondrial network structure versus controls. (C) Kinases identified as required for
normal mitochondrial network structure. RNAi treatments were conducted and scored as in (B) however the listed treatments produced a defect
in the chronic screen but not the acute screen. – Indicates lack of data for a given time point. † Indicates a treatment was classed as producing a
lack of progeny in this screen.
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ment through the contraction and relaxation of many
highly organized sarcomeric units. Additionally, as sarco-
mere structure is conserved from C. elegans through higher
metazoans, C. elegans has become a well-established and
validated model for the study of sarcomere structure and
assembly [28,29].
To examine the effects of kinase knockdown on sarco-
mere structure, we used animals expressing a myosin heavy
chain GFP that localizes to the M-line of sarcomeres [30].
Chronic RNAi knockdown of 50 kinase-encoding genes in-
duced disorganization or tears in the sarcomeric structure
(Figure 3) suggesting that these kinases are required for
normal sarcomere assembly or maintenance. 12% of these
50 genes are already known to be involved in the regulation
of sarcomere structure. For example, pat-4, which encodes
integrin-linked kinase, and which is part of the muscle at-
tachment complex to the basement membrane [31] and
unc-89 and unc-22 which encode the structural proteins
obscurin [32] and twitchin [33], and which play a major
role in the structural integrity of the sarcomeres. To deter-
mine if disrupted sarcomere structure could be accounted
for by a kinase requirement for normal maintenance of sar-
comeres, we knocked down these 50 kinase-encoding genes
acutely in adults. We also acutely knocked down genes for
which a lack of progeny prohibited full analysis in the
chronic screen. Using this approach we identified 34 ki-
nases that appear to be required for proper maintenance of
the sarcomeres (Figure 3). As was the case with our other
two screens for kinome requirement for sub-cellular
processes within muscle, the results of this screen confirm
previous observations and identify several genes for which
no phenotype was previously assigned (Additional file 1).
Multiple subcellular defects are more likely to produce a
developmental or behavioural phenotype
Comparison of single vs. multiple defects within muscle
following RNAi (Figure 4) revealed that kinases appear to
be most frequently required to maintain proteostasis and
least frequently required for normal sarcomere structure.
This result is similar to a past RNAi screen of 159 genes
previously known to influence muscle contraction [12].However, in contrast to this past study, which found an
overrepresentation of genes required for normal protein
homeostasis, mitochondrial network structure and sarco-
mere structure, we found that the distribution of kinases re-
quired to maintain multiple processes within muscle was
not significantly different from a normal distribution (χ2,
GraphPad Prism). However, there was significant enrich-
ment (p < .05, χ2, GraphPad Prism) of developmental or be-
havioural phenotypes amongst the genes for which RNAi
produced defects in sarcomere structure and protein
homeostasis and/or mitochondrial network structure
(Figure 4, bottom three clusters of genes). Taken together,
the results from our study and the past study [12] suggest
that past genetic screens aimed at understanding genes
regulating muscle function, usually contraction, are more
likely to have identified genes that disrupt multiple sub-
cellular processes within muscle than genes that disrupt a
single process (NB 9 of the 10 kinases we identified in all
three screens are well studied). The results also imply that
the genomic control of the metabolic functions of muscle,
such as protein homeostasis and mitochondrial energy pro-
duction, are likely underestimated by past studies aimed at
understanding the genomic control of sarcomere structure
or function [13,14].
Lack of enrichment of any kinase group amongst kinases
identified
We assessed which kinase groups were represented by
the genes identified in each of our three screens. A com-
parison of the number of kinases identified from each
group versus the total number of kinases screened in
each group revealed no statistically significant (χ2,
GraphPad Prism) enrichment of any kinase group. This
lack of enrichment was observed in each screen and for
the total set of kinases identified from all three screens
(not shown).
Epistasis testing of potential degradation-regulating
kinases versus known signals
We conducted epistasis tests to gain further functional
insight into how some of the identified kinases are act-
ing. Because there are well defined signals regulating
Figure 3 (See legend on next page.)
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Figure 3 Kinases that appear to be required for normal sarcomere structure. (A) Sample images of GFP labelled sarcomeres showing
normally aligned sarcomeres in control, non-RNAi treated, PJ727 animal (left) and RNAi treated animals showing sarcomere structure defects.
RNAi treatments are indicated in the lower right corner. Scale bars represent 20 μm. (B) Kinases identified as required for maintenance of normal
sarcomere structure in adult muscle. Indicated RNAi treatments were conducted chronically and followed up acutely and scored for loss of
sarcomere organization, see materials and methods. Displayed are scoring data for each time point (n = 20-30). Green indicates sarcomeres not
appreciably different from controls. Red indicates that at least 25% of scored animals displayed disrupted sarcomere structure versus controls.
Dark red indicates that at least 50% of scored animals displayed disrupted sarcomere structure versus controls. (C) Kinases identified as required
for normal sarcomere structure. RNAi treatments were conducted and scored as in (B) however the listed treatments produced a defect in the
chronic screen but not the acute screen. – Indicates lack of data for a given time point. * Indicates a treatment was classed as producing a lack
of progeny in this screen.
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focused on epistasis testing the genes identified in the
protein degradation screen (Figure 1) against the known
signalling pathways. In C. elegans muscle, presumptive
autophagic degradation is controlled by the balance be-
tween constitutive, autocrine fibroblast growth factor
receptor-Ras-Raf-MAPK signalling [34,35] and insulin
growth factor receptor-PI3K-Akt-Raf signalling [22]. As
with past studies we used unc-51, which encodes
Autophagy-related1 (Atg1) [36], mutants to block au-
tophagic protein degradation and we also used muta-
tions in mpk-1, which encodes mitogen activated protein
kinase (MAPK) [37], and daf-18, which encodes phos-
phatase and tensin homolog kinase [38], to map kinases
required to prevent cytosolic protein degradation to
activation of the autophagic signalling pathways in C.
elegans. Proteasomal degradation appears to be con-
trolled by plasma membrane polarization [12] and in-
creased degradation by this system can be observed in
response to starvation [17], denervation [39], and
neurodegeneration [40]; as with past studies we used
the proteasome inhibitor MG132 to block any degrad-
ation which required proteasomal activity [39].
For 21 of 48 kinases, β-galactosidase degradation was
suppressed in the unc-51 and mpk-1 mutant strains
suggesting that close to half of the kinases for which
knockdown triggered muscle protein degradation are
causing increased MPK-1 mediated autophagic protein
degradation (Figure 5). To confirm autophagy was
triggered by knockdown of each of the 21 kinases, we
examined the accumulation of autophagic vesicles in re-
sponse to knockdown in animals expressing GFP fused
to the autophagic vesicle marker LGG-1 [36]. As shown
in Figure 6, a significant increase in autophagic vesicles
was observed in response to knockdown of each of these
21 genes (p < .0001, one way ANOVA, GraphPad Prism).
These results suggest that autophagic protein degrad-
ation is the proteolytic mechanism most commonly
triggered by decreased expression of an individual kin-
ase. Consistent with this, knockdown of only 6 kinases
appeared to trigger proteasome-mediated degradation as
evidenced by lack of degradation in the MG132 treat-
ment condition. Two of these kinases, IRE-1 and PEK-1,are well conserved regulators of the endoplasmatic
reticulum unfolded protein response which modulates
both autophagic and proteasomal degradation. For 21
of the 48 kinases, β-galactosidase degradation was
suppressed in daf-18 animals suggesting that knock-
down of these kinases alters signalling in an insulin-
mediated pathway. The majority of these kinases also
require MPK-1 and UNC-51, which is therefore consistent
with past studies of signalling networks controlling protein
degradation in C. elegans muscle. Included in this group
are sgk-1 [21], gsk-3 [20] and the gene that encodes AMP-
activated protein kinase [41], each of which is already
known to be part of insulin-mediated control of protein
homeostasis in other species. Additionally, 10 kinases
appeared to trigger an as yet unidentified proteolytic
mechanism as β-galactosidase degradation upon RNAi
knockdown was not suppressed in the mutants or in
MG132 treated animals. One of these genes is pat-4 for
which calpains have recently been demonstrated to be the
regulated protease [15]. While future study may uncover
the details of the other potentially novel mechanisms, it is
interesting that autophagy was triggered in response to
roughly half of the kinase knockdowns in C. elegans.
Discussion
We have used RNAi to knock down the vast majority of
the C. elegans kinome to examine the kinome require-
ment for establishing and maintaining sub-cellular pro-
cesses within muscle. The use of C. elegans and RNAi
has allowed us to define a preliminary in vivo functional
kinome requirement for muscle which currently remains
technically and economically challenging to establish in
rodents and infeasible in human subjects. The evolution-
ary distance between the C. elegans and the human
kinome suggests that not all results obtained in this
study will be relevant to man and that there are some
important kinases that we have not studied as they do
not exist in C. elegans. However, our identification of
kinases as required for normal subcellular processes in
C. elegans muscle that are already known to regulate the
same subcellular process(es) in mammals, suggests that
some, if not many, of our results will be relevant to
higher metazoans. Similarly, while our use of RNAi by
Figure 4 (See legend on next page.)
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Figure 4 Kinases that appear to be required for multiple subcellular processes to be normal. (A) Kinases identified as required for normal
muscle protein homeostasis and mitochondrial structure (e.g. kinases identified in both the proteostasis screen and mitochondrial structure
screen in Figures 1 and 2), kinases identified as required for normal muscle protein homeostasis and sarcomere structure (e.g. from the
proteostasis and sarcomere screens), kinases identified as required for normal mitochondrial and sarcomere structure (e.g. from the mitochondrial
and sarcomere screens), and kinases identified as required for normal muscle protein homeostasis and mitochondrial and sarcomere structure
(e.g. from all three screens). ‡, †, * Indicates a treatment was classed as producing a lack of progeny in the proteostasis, mitochondria, or
sarcomere screen, respectively. Kinases listed on the left relate to colour coded affected subcellular processes and presence of a developmental
or behavioural phenotype on the right as described in inset legend. (B) Venn diagrams displaying number of kinases which are required for a
single process to be normal (data extracted from Figures 1, 2 and 3) and number of kinases required for multiple processes to be normal (grey)
during muscle development (left) and/or in adult muscle (right). Colour codes match inset legend. Diameter of circles relate to total number of
kinases which are required for this process to be normal.
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functional kinome requirement for muscle, our use of
this single method will almost certainly have caused us
to overlook certain kinases. For example, RNAi by feed-
ing does not produce a reproducible quantitative knock-
down from animal to animal [42,43]. Thus, negative
results and quantitative differences in defects in re-
sponse to RNAi against different genes are not interpret-
able, as it is experimentally challenging to demonstrate
quantitative knockdown in the same worm that is scored
for subcellular defects and economically not feasible on
the scale of the work reported here. Similarly, as the
knockdowns occur in the whole animal it is not possible
to definitively conclude if it is the knockdown of the
targeted gene or another gene that is producing the ob-
served defect nor is it possible to conclude if it is the
knockdown in muscle, another tissue, or both that is
producing the observed defect. Clearly future studies in
kinase gene mutants are required, as are demonstrations
of the tissue(s) in which each kinase is required for es-
tablishment and/or maintenance of muscle homeostasis.
The recent availability of knockouts for most of the C.
elegans kinome [44] should facilitate such future studies.
Our approach of observing several sub-cellular pro-
cesses allowed us to analyse differences in the kinome
requirement for multiple subcellular processes. For each
of the processes studied there appear to be many more
specific kinases required than kinases required for mul-
tiple processes to be normal within muscle. Thus, it does
not appear to be the case that for the majority of the
kinome disruption of any one individual kinase results
in complete loss of cellular homeostasis. Our data also
show that the two general cellular processes, cytosolic
protein homeostasis and mitochondrial dynamics, ap-
pear to be more frequently affected by kinase RNAi
knockdown than the muscle specific process of assembly
and maintenance of sarcomeres. This raises the question
whether there has been more frequent evolutionary se-
lection for kinases required for general, metabolic pro-
cesses over those required for other, more specialized
cellular processes. Similarly, our observations raise the
question whether processes more heavily impacted bykinome knockdown, such as protein homeostasis, are
more tolerant of dysregulation without catastrophic fail-
ure. If so, this might explain why only 31% of defects in
cytosolic protein homeostasis resulted in overall defects
in behaviour or development in comparison to 48% of
defects in sarcomeres. Together these observations sug-
gest that further analysis of sub-cellular phenotypes or
conditional phenotypes should allow assignment of puta-
tive function to the entire kinome of C. elegans.
Our use of chronic and acute RNAi screens revealed
that the majority of kinases appeared to be required for
the same subcellular processes during development as in
terminally differentiated cells. This observation suggests
that a large number of kinases that influence development
continue to have an important function in the biology of
fully differentiated cells; it may be that cellular regulatory
networks are established during development. While it
remains to be seen if the kinases regulate development
and physiology and do so via identical mechanisms, the
observation of conserved effects of knockdown during
development and in fully differentiated muscle suggests
that candidate drug targets could be selected based upon
known roles of genes in the development of tissues of
interest.
It remains to be seen if our findings are general fea-
tures of the kinome in tissues outside of muscle but our
identification of kinases that were already known to ubi-
quitously control protein homeostasis and mitochondrial
dynamics suggests that at least some of the kinases iden-
tified are likely to affect these processes in other tissues.
Additionally, as insulin/insulin growth factor receptor is
a general controller of cell size, presumably as the result
of MAPK dependent control of the overall rate of trans-
lation [45], our observation that functional MAPK is re-
quired to produce protein the degradation observed in
response to knockdown of most kinases suggests that
our observations may be not specific to muscle.
Conclusions
We identified 159 kinases for which RNAi knockdown in-
duced defects in single or multiple sub-cellular processes
in muscle. Some of the identified genes were already
Figure 5 (See legend on next page.)
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Figure 5 Epistasis testing of kinases apparently required to prevent protein degradation against known pathways. (A) The 48 kinases that
were identified as required to prevent protein degradation (Figure 1B) were examined for potential interaction with known proteolytic signalling
pathways in C. elegans muscle [22,34,39]. For these experiments the acute RNAi screen, see materials and methods, was rerun on a control set of PD55
animals (not shown) and on PJ1009 (unc-51(e369), which has been shown to block autophagic degradation [22]), PD55 treated with MG132 (which has
been shown to block proteasomal degradation [39]), PJ1103 (mpk-1(n2521), which has been shown to block degradation resulting from excessive FGFR
or insufficient IGFR signalling [22]), and PJ1132 (daf-18(e1375), which has been shown to block degradation resulting from excessive FGFR or insufficient
IGFR signalling[22]). At least two independent experiments per gene per strain were performed, with a third and/or more run in case of discrepant
results. (B) Kinase knockdowns identified as requiring autophagy, the proteasome, or another proteolytic system to induce degradation are indicated
by the columns on the left. Kinase knockdowns identified as requiring MPK-1 and/or DAF-18 for muscle protein degradation are indicated by the
columns on the right. The observation, or lack of observation, of protein degradation caused by knockdown of the indicated kinase (middle columns),
in at least 2 experiments, in each of the test conditions is indicated by a colour code for which an inset legend is provided.
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we also identified and therefore support the validity of this
study. Most of the genes identified are new requirements
for subcellular processes examined. For 51 of the identi-
fied genes no behavioural or developmental phenotype
had previously been reported in functional genomics
screens. Thus, our results provide measurable phenotypes
to enable more detailed analyses of specific kinases that
previously could not be studied in vivo and bring the por-
tion of the C. elegans kinome that has a known function
close to 75%. Lastly, our results may have application to
clinical conditions associated with loss of muscle
homeostasis. For example, 33% of kinases identified as
required for C. elegans muscle homeostasis have human
orthologues expressed in muscle (Additional file 1).
Thus, some of these kinases may serve as the intramuscu-
lar transducers of known extramuscular factors that con-
trol muscle homeostasis. In this context, it is interesting to
note that MAPK appears to be a central regulator of
muscle protein degradation in C. elegans and the classical
MAPK, extracellular-signal regulated kinase (ERK) is
known to be functional in adult human muscle [46].
Materials and methods
Nematode handling and strains utilized
Nematode strains were maintained and grown at 20°C
using Escherichia coli strain OP50 as a food source. Strains
used were CB5600 (ccIs4251 I; him-8(e1489) IV), CC25
(pink-1 (tm1779) II), CC46 (ccIs4251 I; pink-1(tm1779) II;
him-8(e1489) IV), PD55 (ccIs55 V), PJ727 (jIs01; ccIs55 V),
PJ1009 (unc-51(e369), ccIs55 V), PJ1103 (mpk-1 (n2521) III;
him-8 (e1489) cha-1(1182ts) IV; ccIs55 V), PJ1132 (daf-18
(e1375) IV; ccIs55 V), and KAG146 (kagEx12 (pKG169
(pdyc-1S::gfp::lgg-1) + pCFJ190(pmyo-2::mcherry) + pBSC)).
pink-1 mutant strains were constructed using standard
techniques [47], with the presence of pink-1 homozygotes
confirmed by PCR (primers forward 5′ tcattaggatctcgcttgag;
reverse 5' agcctcgggcttattaagga).
Identification and source of RNAi clones utilized
The global list of C. elegans kinases [5] was used to search
for RNAi bacterial feeding clones previously utilized todetermine the effect of knockdown of roughly each gene in
the genome upon development and behaviour [6,7]. These
identified clones were obtained from Source BioScience
(Nottingham, UK). Additionally, a clone against let-363 was
obtained from the University of Colorado [48]. After se-
quence verifying all positive results from our screen, we
identified that previously utilized RNAi constructs were
available for 397 kinase-encoding genes, which comprised
91% of the C. elegans kinome; clone names beginning with
a roman numeral arise from the Ahringer C. elegans RNAi
library [6] while clones names beginning with an Arabic
number arise from the Vidal ORF RNAi library [7]
(Additional file 1).
Quality control of our RNAi screens
A schematic of how the three screens were performed is
provided (Figure 7). RNAi using bacterial clones grown
as described [6] was performed with both chronic and
acute RNAi experiments as described previously [12]. A
detailed technical description of the strengths, limita-
tions, and caveats to interpretation of results from this
screening methodology is available elsewhere [43].
We used RNAi against unc-112 as a positive control as
RNAi unc-112 has been shown to produce a develop-
mental, behavioural, muscle protein degradation, mito-
chondrial, and sarcomere defect [15]. Each of the three
screens was run in parallel such that the same genes
were assessed in the same week, typically 20 genes/week.
In cases where the positive control did not provide an
abnormal phenotype in each of the screens the entire
batch of genes was rerun with an unc-112 positive
control.
We used previously utilized RNAi constructs so that
we could directly compare our results for developmental
phenotypes with those of others who previously utilized
the same RNAi construct as a quality control measure.
The false positive rate for developmental and behavioural
phenotypes observed in response to RNAi by feeding in
C. elegans is <1%, thus thresholds were set for ease of
scoring. Developmental phenotypes were recorded if at
least 20% of worms on the RNAi seeded plate showed a
phenotype and also if the same phenotype was observed
Figure 6 (See legend on next page.)
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Figure 6 Increased autophagic vesicles are present in muscles following knockdowns appear to trigger autophagy. (A) Sample images
of GFP labelled autophagic vesicles showing normally low levels in a control RNAi treated KAG146 animal (left) and an experimental RNAi treated
animal showing increased vesicles. RNAi treatment is indicated in the lower right corner. Scale bars represent 20 μm. (B) Each of the 21 kinase
knockdowns that were identified as requiring autophagy to produce increased protein degradation displayed an increase in autophagic vesicles
following 24 hours of acute RNAi treatment. Three independent experiments were performed (n = 20 each). Error bars represent standard error of
measurement. ** p < 0.0001, one way ANOVA.
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worms (NB there was no similar change in threshold in
the sub-cellular phenotype analyses). Developmental/be-
havioural phenotypes scored were: Unc (uncoordinated
movement), Rol (rolling movement), Bmd (abnormal body
morphology), Dpy (short fat appearance), Pvl (protrusion
from the vulva), Rup (rupture from the vulva), Ste (sterile),
Egl (egg laying defective), Emb (embryonic lethal) and Gro
(long period of development and/or growth arrest). For a
complete list of phenotypic results see Additional file 1.
Comparison of phenotypes from our study to previously
published phenotypes were made using www.wormbase.
org. Comparison of the developmental and behavioural
phenotypes we observed in response to RNAi with past
studies that utilized the same RNAi construct revealed a
false negative rate of 4% (NB two-thirds of these pro-
duced a sub-cellular defect in one or more of our
screens), a divergence in phenotype observed of 2%, and
a first observation of a phenotype using the RNAiFigure 7 Systematic identification of kinases required for normal sub
feeding clones against 397 kinase-encoding genes were performed. Screen
each screen, all genes were assessed for the effect of RNAi upon a single s
in each screen). (A) All genes were assessed for the effect of chronic, multi
screen, CB5600 for the mitochondrial network structure screen, and PJ727
progeny were observed on two consecutive days using light microscopy a
epifluorescence microscopy for the mitochondrial or sarcomere screens. (B
of progeny were assessed for the effect of acute, single generation RNAi kn
using light microscopy after staining for β-galactosidase in the protein deg
or sarcomere screen (to confirm normal baselines) and then allowed to gro
were taken 24*, 48, and 72 hours after being placed on RNAi plates. *24 hoconstruct for 13% of genes studied. These figures are
consistent with another recent study of the efficacy of
the method we chose to employ [12] and are an im-
provement upon the roughly 30% false negative rate
typically reported for RNAi by feeding in C. elegans. A
detailed discussion of why our false negative rate is
lower and our first discovery of function rate is higher
than past studies as well as other technical details of
improving results from RNAi screens can be found else-
where [43].
All RNAi feeding clones for which a sub-cellular defect in
muscle was scored as positive were sequence verified using
Source BioScience LifeScience’s Bugs2Bases service or
using Source BioSciences’ sequence verified clone service.
In order to maximize usable returned sequence data, a
combination of three primers were utilised separately for
each clone: C.elegans RNAi F from the Source BioScience
library, forward 5′ ggagaccggcagatctgata, and reverse 5′
ggcctcttcgctattacgc. Sequence data was analysed using-cellular processes in muscle. Three parallel screens using RNAi
s were run in parallel on the same genes, typically 20 per week. In
ub-cellular process within muscle (using a different transgenic reporter
-generational RNAi knockdown. PD55 was used for the proteostasis
for the sarcomere structure screen. Upon reaching adulthood, F1 or F2
fter staining for β-galactosidase in the proteostasis screen or
) In each screen, identified genes and treatments that resulted in a lack
ockdown in age synchronized adults. Adult worms were observed
radation screen or epifluorescence microscopy for the mitochondrial
w on RNAi plates for an additional 72 hours. Additional measurements
ur measurements were only taken in the protein degradation screen.
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elegans BLAST for confirmation of correct sequence.
Assessment of proteostasis, proteolysis, mitochondrial
network structure, and sarcomere structure via transgenic
reporter proteins
Muscle-specific protein homeostasis and protein degrad-
ation was assessed using transgene ccIs55 (unc-54::lacZ),
with histochemical staining for β-galactosidase activity
as described [17]. The protein product of ccIs55 is con-
tinually synthesized throughout development and re-
mains stable (e.g. is neither synthesized nor degraded) in
the cytosol for the first 72–96 hours post adulthood
in wild-type animals [15,17,22,35,39]. Thus, alterations
in β-galactosidase activity observed in response to
chronic RNAi indicate alterations in protein synthesis
and/or degradation whereas alterations in response to
acute RNAi applied to fully developed adults indicate ac-
tivation of protein degradation alone.
Muscle-specific mitochondria and nuclei were assessed
using transgene ccIs4251(Pmyo-3::MitGFP; Pmyo-3::NLS::
GFP-lacZ), with epifluorescence microscopy as described
[12]. Note that observations and images were taken of live,
non-immobilized animals. This was achieved by capturing
images while the animal was still.
Sarcomere structures were assessed using transgene
jIs01(myo-3::GFP) which produces a translational fusion
of the full-length MYO-3 (myosin heavy chain A) gene
to GFP, with epifluorescence microscopy as described
[12]. Note that observations and images were taken of
live, non-immobilized animals. This was achieved by
capturing images while the animal was still.
Scoring criteria and procedure for each of the RNAi
screens
Sub-cellular phenotypes scored in each of the three
screens were: Cytosolic protein content (normal, abnor-
mal), mitochondrial morphology (normal, abnormal), and
sarcomere morphology (normal, abnormal); see Figures 1,
2 and 3, respectively, for examples of normal and abnor-
mal sub-cellular phenotypes. In all cases abnormalities
deemed minor (e.g. not appreciably different from RNAi
control) were scored as normal. Observations were scored
as abnormal if defects were observed in at least 25% of
worms on the slide (NB this is a 5% increase in threshold
from the study [12] upon which this protocol is based).
Defects, within an individual worm, were classed using the
same thresholds as from the study upon which this proto-
col is based [12], as follows: i) cytosolic protein content: at
least a 30% loss of stain (e.g. intensity viewed as light blue
or absent in contrast to dark blue); ii) mitochondrial
morphology: loss of at least 30% of the mitochondrial
network in at least two muscle cells (e.g. loss of linear
networks that was significant enough to be noticeable anddifferent from control animals). iii) sarcomere morph-
ology: at least 2 disorganized or broken arrays of sarco-
meres in at least two muscle cells (e.g. loss of linear arrays
of sarcomeres that was significant enough to be noticeable
and different from control animals). All scoring was done
manually using a Nikon H600L microscope.
For chronic RNAi exposures (Figure 7A), a defect had
to be observed in any two of the four time points exam-
ined to be scored as positive. Genes for which lack of pro-
geny prevented scoring were also scored as giving a defect
for the purposes of further examination. Genes that were
identified as affecting cytosolic protein content, mitochon-
drial structure, or sarcomere structure in chronically
treated animals were then examined for effects of acute
RNAi exposure.
For acute RNAi exposures (Figure 7B), a defect had to
be observed at any two time points after introduction to
RNAi, with particular attention to progressive loss of
cytosolic protein between the 48 and 72 hour time
points. The criteria for a positive score at a single time
point are identical to those described for the chronic
RNAi screens.
For all observations, 4–6 representative images were
captured on a Nikon H600L microscope with a Nikon
Digital Sight DS-Fi1 digital camera and proprietary soft-
ware. At the end of all of the screens, these images were
used to confirm the results from the screen. Addition-
ally, at the end of all screens all images were reviewed by
an independent observer to confirm or correct initial
scoring. In cases of a discrepancy between the first and
second individual scoring the images the last author
manually reviewed the data and the two sets of scoring
in order to reach a final scoring.
Epistasis testing of identified genes against known
protein degradation pathways
Mutants and MG132 used for clustering identified genes
to known proteolytic pathways/mechanisms were as de-
scribed [12]. Acute RNAi experiments with these mu-
tants were performed as described [12]. Degradation was
scored as in acute RNAi treatments in two independent
experiments; in case of discrepancy a third experiment
was run.
Assessment of autophagic vesicles via transgenic reporter
protein
Muscle-specific autophagic vesicles were assessed using
transgene kagEx12(pdyc-1S::gfp::lgg-1), with epifluores-
cence. Transgenic animals were synchronised and sub-
ject to the acute RNAi protocol with scoring occurring
at 24 hours post introduction to RNAi clone or a control
clone lacking a targeted sequence. Autophagic vesicles
were quantified within the two body wall muscles that
visually appeared to contain the greatest number of
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RNAi treatment with 20 animals per experiment and
each experiment run three times. Two or three RNAi
clones with a separate control clone were analysed at
once.
Statistics
All statistical analysis was undertaken utilizing GraphPad
Prism (GraphPad Software, Inc., La Jolla, CA, USA). For
assessment of distributions of data being significantly dif-
ferent from a normal distribution, χ2 analysis was used.
For assessment of tested RNAi clone autophagic vesicle
data being significantly different from control RNAi clone,
one-way ANOVA with Dunnett’s multiple comparison test
was used.
Additional file
Additional file 1: The following additional data are available with
the online version of the paper. A comprehensive list of genes
screened, clones used, and results. Sheet “All genes screened” provides
information and results for 397 genes screened including the bacterial
clone used in this study, subcellular defects observed as indicated by
colour coding (see legend at bottom) and developmental phenotypes
observed, known human orthologues along with data on expression in
human muscle. Sheet “no clones available” displays all genes for which
an existing bacterial clone in the C. elegans RNAi library/Ahringer and C.
elegans ORF-RNAi library/Vidal libraries was not available or for which
sequencing suggests it may contain an incorrect target sequence.
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